In vernal and atopic keratoconjunctivitis, inflammatory involvement of the eyelid skin represents a distinct aspect of disease management. When eyelid involvement is present in eligible patients, a specific treatment approach applies that differs from conjunctival management alone.
Eyelid involvement of vernal or atopic keratoconjunctivitis in patients aged 2 years or older. Age-specific considerations guide the selection of appropriate topical therapy for the affected eyelid skin.
The protocol addresses eyelid skin involvement with topical therapy. Age-stratified options are defined for the paediatric and adult populations — the complete agent selection and age-based guidance is detailed in the full regimen.